Abstract:Myocardial ischemia and reperfusion (I/R) injury is well known in therapy for acute coronary syndrome and open heart surgery. Although reperfusion therapy (such as thrombolysis and percutaneous coronary intervention) is essential for the survival of ischemic tissue, reperfusion itself causes additional cellular injury. I/R could cause local myocardial inflammation, accompanying with apoptosis, which could result in myocardial cell damage [ [1] Frangoginis N.G. Smith C.W. Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002; 53: 31-47 Crossref PubMed Scopus (1704) Google Scholar ]. High mobility group box 1 protein (HMGB1), a highly conserved nuclear protein, could regulate gene transcription and maintain the nucleosome structure. HMGB1 could be passively released from necrotic cell, apoptotic cell or actively secreted by innate immune cells (such as macrophages and monocytes) [ 2 Scaffidi P. Misteli T. Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002; 418: 191-195 Crossref PubMed Scopus (3284) Google Scholar , 3 Bell C.W. Jiang W. Reich C.F. et al. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol. 2006; 291: C1318-C1325 Crossref PubMed Scopus (417) Google Scholar ]. Recently, a present study shows that HMGB1 acts as a novel early mediator of inflammation and participates in the pathogenesis of myocardial I/R injury, and HMGB1 could promote the release of tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6), whereas HMGB1 A box peptide (a specific HMGB1 antagonist) could reduce myocardial ischemia and reperfusion injury and inhibit the release of TNF-α and IL-6 [ [4] Andrassy M. Volz H.C. Igwe J.C. et al. High-mobility group box-1 in ischemia–reperfusion injury of the heart. Circulation. 2008; 117: 3216-3226 Crossref PubMed Scopus (518) Google Scholar ]. Meanwhile, lots of drugs have been found to reduce myocardial I/R injury by inhibiting HMGB1 expression, including asperosaponin X [ [5] Jiang W.L. Zhang S.P. Zhu H.B. et al. Cardioprotection of asperosaponin X on experimental myocardial ischemia injury. Int J Cardiol. 2011; https://doi.org/10.1016/j.ijcard.2011.06.010 Abstract Full Text Full Text PDF Scopus (25) Google Scholar ], minocycline [ [6] Hu X. Zhou X. Xu C. et al. Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Eur J Pharmacol. 2011; 654: 274-279 Crossref PubMed Scopus (14) Google Scholar ], ethyl pyruvate, [ [7] Hu X. Cui B. Zhou X. et al. Ethyl pyruvate reduces myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Mol Biol Rep. 2012; 19: 227-231 Crossref Scopus (47) Google Scholar ] etc. These suggested that HMGB1 may play an important role in myocardial I/R injury and inhibiting HMGB1 could reduce myocardial I/R injury.

HMGB1 Protects the Heart Against Ischemia–Reperfusion Injury Via PI3K/AkT Pathway-Mediated Upregulation of VEGF Expression

Involvement of GC in Effect of Heme Oxygenase-1 on Cardioprotection from Ischemia/reperfusion Induced injury

HMGB1: A Potential Therapeutic Target for Myocardial Ischemia and Reperfusion Injury

Exogenous High-Mobility Group Box 1 Protein Injection Improves Cardiac Function after Myocardial Infarction: Involvement of Wnt Signaling Activation

MiR-129-5p Protects Against Myocardial Ischemia-Reperfusion Injury Via Targeting HMGB1

Abstract 19689: Kdm3a Protects Myocardium from Ischemia/reperfusion Injury Through Targeting Akt-dependent Signaling Pathways

Exogenous High‐mobility Group Box 1 Protein Prevents Postinfarction Adverse Myocardial Remodeling Through TGF‐β/Smad Signaling Pathway

Simvastatin Protects the Heart Against Ischemia Reperfusion Injury Via Inhibiting HMGB1 Expression Through PI3K/Akt Signal Pathways

Intramyocardial Delivery of HMGB1 by a Novel Thermosensitive Hydrogel Attenuates Cardiac Remodeling and Improves Cardiac Function after Myocardial Infarction.

Glycyrrhizin Protects Rat Heart Against Ischemia- Reperfusion Injury Through Blockade of HMGB1- Dependent Phospho-Jnk/bax Pathway

EXOGENOUS HIGH MOBILITY GROUP BOX 1 PROTEIN IMPROVES CARDIAC FUNCTION AFTER MYOCARDIAL INFARCTION IN RATS

Anti-inflammatory Effect of B-type Natriuretic Peptide Postconditioning During Myocardial Ischemia-Reperfusion: Involvement of PI3K/Akt Signaling Pathway.

PI3K/Akt Signaling Pathway Involved in Cardioprotection of Preconditioning with High Mobility Group Box 1 Protein During Myocardial Ischemia and Reperfusion

High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRα-positive bone marrow cells

GW24-e1183 Intramyocardial Delivery of HMGB1 by a Novel Thermosensitive Hydrogel Attenuates Cardiac Remodeling and Improves Cardiac Function after Myocardial Infarction

Vascular Endothelial Growth Factor-C Protects Heart from Ischemia/reperfusion Injury by Inhibiting Cardiomyocyte Apoptosis

Effects of HMGB1 on MMP-9 Expression in Rat Cardiac Fibroblasts

Influence of Ethyl Pyruvate Preconditioning on Myocardial Ischemia and Reperfusion Injury and HMGB1 Expression in Rats

HMGB1 Induces Apoptosis and EMT in Association with Increased Autophagy Following H/R Injury in Cardiomyocytes.

The HMGB1‑IL‑17A Axis Contributes to Hypoxia/reoxygenation Injury Via Regulation of Cardiomyocyte Apoptosis and Autophagy.

Transduction and Effect of Heme Oxygenase-1 Mediated by Cell Penetrating Peptide PEP-1 on Myocardial Ischemia in Rats